PRESS RELEASE
News
-
-
-
PRESS RELEASE
Condor Resources Announces Life Offering Private Placement of Up to $1.5 Million
Condor Resources Inc. announces non-brokered private placement of up to 12,500,000 units at $0.12 per Unit for gross proceeds of $1,500,000. Proceeds to be used for exploration and corporate purposes. Closing expected on April 30, 2025 -
PRESS RELEASE
Original-Research: Knaus Tabbert AG (von First Berlin Equity Research GmbH): Kaufen
First Berlin Equity Research GmbH has published a comprehensive update on Knaus Tabbert AG confirming a Buy recommendation with a target price of €29 as the company undergoes restructuring led by the new CEO Wim de Pundert -
-
-
PRESS RELEASE
Lobe Sciences Ltd. Announces Private Placement to Support Drug Development of Novel Conjugated Psilocin(TM)
Lobe Sciences announces US$6M private placement for Cynaptec to fund Conjugated Psilocin development. Option for additional US$20M included. Company focuses on lipid tech for orphan diseases -
-
PRESS RELEASE
Ascendant Resources Notifies Shareholders Of Upcoming Special Meeting
Ascendant Resources Inc. announces special meeting for shareholder vote on acquisition by Cerrado Gold Inc. under Section 182 of the Business Corporations Act (Ontario) and recommends FOR vote. Proxies due May 2, 2025 -
PRESS RELEASE
Measles Outbreak Expands Begging for a Drug to Treat the Infection - NanoViricides Declares it is Ready to Fight the Outbreak
NanoViricides, Inc. commences evaluation of clinical drug NV-387 for Measles virus treatment, utilizing innovative nanomedicine technology. Company aims to combat Measles outbreak and provide effective antiviral solution
